RA
SZYM

Royce & Associates’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Royce & Associates’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-196,718
Closed -$508K – 1341
2014
Q4 		$508K Sell
196,718
-687,447
-78% -$3.01M ﹤0.01% 1132
2014
Q3 		$6.6M Buy
884,165
+267,000
+43% +$2.49M 0.02% 745
2014
Q2 		$7.27M Buy
617,165
+266,218
+76% +$2.84M 0.02% 775
2014
Q1 		$4.07M Buy
350,947
+146,000
+71% +$1.72M 0.01% 928
2013
Q4 		$2.23M Buy
204,947
+189,947
+1,266% +$1.87M 0.01% 1046
2013
Q3 		$162K Buy
+15,000
New +$171K ﹤0.01% 1314

Other funds holding SZYM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PC
Passport Capital San Francisco, California $394M AUM 50.67% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royce & Associates's SZYM Position: Q1 2015 in Review

Royce & Associates sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q1 2015, closing a stake of 196,718 shares — an estimated $508K sold.

Royce & Associates first reported a position in SZYM in Q3 2013 and held it in 6 quarters. The position peaked at $7.27M in Q2 2014. 102 funds tracked by Wall St. Rank hold SZYM as of Q1 2015.

  • Royce & Associates reported no remaining SOLAZYME INC COM STK (DE) position as of Q1 2015 after selling out during the quarter.
  • Royce & Associates sold 196,718 SOLAZYME INC COM STK (DE) shares in Q1 2015, an estimated $508K.
  • Royce & Associates first reported a position in SOLAZYME INC COM STK (DE) in Q3 2013 and held it in 6 quarters.
  • Royce & Associates's SOLAZYME INC COM STK (DE) position peaked at $7.27M in Q2 2014.
  • 102 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q1 2015.

Based on Royce & Associates's 13F filing for Q1 2015, filed 13 May 2015.